Burns

·MeSH: Burns

10 drugs in development·9 companies·3 clinical trials

Drug Pipeline by Phase

Approved(9)

Drug	Company
accelerex sterile wound	REGENEREX PHARMA, INC. (RGPX)
altrazeal	ULURU INC. (ULU)
cohealyx	Avita Medical Inc. (RCEL)
Epicel	Vericel Corp (VCEL)
grafix	OSIRIS THERAPEUTICS, INC. (OSIR)
HELIOGEN Fibrillar Collagen Matrix	MiMedx Group Inc (MDXG)
Luxamend	Journey Medical Corp (DERM)
nexobrid	MediWound Ltd. (MDWD)
NexoBrid	Vericel Corp (VCEL)

Phase 2(1)

Drug	Company
cp12	G1 Therapeutics, Inc. (GTHX)

BioSniper tracks 10 drugs in development for Burns across 9 companies.

There are 3 clinical trials targeting Burns tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.